Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000081755

Meso Scale Discovery U-PLEX NHP MIF ASY384-well
SDP

Catalog No. 5000081755
Encompass

The U-PLEX NHP MIF 384-Well Assay from Meso Scale Discovery is a 384-well multiplex immunoassay that enables simultaneous detection of multiple human neurodegenerative biomarkers This assay measures A 38 A 40 A 42 -synuclein p-tau181 t-tau and neurogranin in human CSF and plasma samples using electrochemiluminescence detection technology The assay utilizes Meso Scale Discovery s proprietary U-PLEX technology and provides high sensitivity broad dynamic range and minimal matrix interference for biomarker quantification With a small sample volume requirement and 384-well format this assay allows efficient processing of large sample sets

Catalog No. 50-000-81755 Supplier Meso Scale Discovery Supplier No. K256XJK2
May include imposed supplier surcharges.
Add to Cart
Add to Cart
Request a Quote

missing translation for 'validMainframeMsg'

The U-PLEX NHP MIF 384-Well Assay from Meso Scale Discovery is a 384-well multiplex immunoassay that enables simultaneous detection of multiple human neurodegenerative biomarkers This assay measures A 38 A 40 A 42 -synuclein p-tau181 t-tau and neurogranin in human CSF and plasma samples using electrochemiluminescence detection technology The assay utilizes Meso Scale Discovery s proprietary U-PLEX technology and provides high sensitivity broad dynamic range and minimal matrix interference for biomarker quantification With a small sample volume requirement and 384-well format this assay allows efficient processing of large sample sets

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.